Inflammatory Bowel Disease Market

Phone: +44 (0) 161 359 5813 Email: reportstore@globaldata.com

Browse the variety of reports GlobalData has to offer to help you make effective decisions in the Inflammatory Bowel Disease Market.

Oct-2018

2

GlobalData’s coverage of the inflammatory bowel disease (IBD) space includes in-depth market analyses and forecasts for both Crohn’s disease and ulcerative colitis (UC), along with a look at the digital marketing landscape for IBD. This series of reports provides expert-driven insight on the current and future treatment landscape, key unmet needs, and opportunities to compete in the IBD market.

Digital Landscape

Epidemiology Forecast to 2026

Inflammatory Bowel Disease Market - 3 Report Types

Includes a 10-year epidemiological forecast for diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases (both diagnosed and undiagnosed) segmented by sex and age (starting at 0-9 years and ending at 80 years and older) in these markets.

Learn about the digital activities being undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe diseases.

Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the market.

Global Drug Forecast and Market Analysis

to 2026

3

Inflammatory Bowel Disease Market - 3 Report Types

Our Report Store offers the latest comprehensive reports, market data, analysis and survey findings alongside industry

information on key companies, markets and financial deals.

Purchase directly from our store or review the below pricing and contact us for a bespoke deal that meets your companies

needs.

Phone: +44 (0) 161 359 5813

Email: reportstore@globaldata.com

Report Type Price (Single User) Countries Covered Discounts for multiple

report purchase

Global Drug Forecast and Market Analysis to 2026

$10,995 Global Reports

Digital Landscape $6,000 Global Reports

Epidemiology Forecast to 2026 $3,995 Global Reports

© GlobalData 2018. This product is licensed and is not to be photocopied.

Global Drug Forecast and Market Analysis Each report will allow you to:

Develop and design your in-licensing

and out-licensing strategies through a

review of pipeline products and

technologies, and by identifying the

companies with the most robust

pipeline.

Develop business strategies by

understanding the trends shaping and

driving the global therapeutics market.

Drive revenues by understanding the key

trends, innovative products and

technologies, market segments, and

companies likely to impact the

therapeutics market in the future.

GlobalData’s Global Drug Forecast and Market Analysis reports provide an overview of the specific disease, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies. Key topics covered include current treatment options, unmet needs and opportunities, and the drivers and barriers affecting therapeutics sales.

Price: $10,995 Single User License Format: Electronic pdf

© GlobalData 2018. This product is licensed and is not to be photocopied.

Digital Landscape Our Digital Landscape report series provides an analysis of pharma multichannel activity in the digital space, and can assist you to derive value in a number of ways:

Competitive Intelligence: Track and compare key competitor

activity across channels and identify key trends.

Digital Strategy: Strengthen corporate digital excellence, learn

from industry best practice, and identify opportunities for novel

digital campaigns.

Support new brand launch: See best practice examples of pre-

and post-launch digital activities, ascertain must-have digital assets

for patient and HCP engagement, and assess potential gaps and

opportunities for pipeline brands.

Business Development & Licensing: Assess topics and trends

shaping digital health, and learn about key patient and physician

online activities.

Price: $6,000 Single User License

Format: Electronic pdf

© GlobalData 2018. This product is licensed and is not to be photocopied.

Epidemiology Forecast GlobalData’s Epidemiology Forecast reports include a 10-year

forecast for the diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases (both diagnosed and undiagnosed) of a specific disease, segmented by sex and age (starting at ages 0–9 years and ending at ages 80 years and older. The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 7 major markets (7MM). The Epidemiology Forecast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies.

Price: $3,995 Single User License

Format: Electronic pdf

“Overall a very thorough report and comparable, if not superior, in content to similar reports by

other reputable firms.”

Vice President, Corporate Development, Afraxis, Inc.

About GlobalData GlobalData is a leading global provider of business intelligence in the Healthcare industry. GlobalData provides its clients with up-to-date information and analysis on the latest developments in drug research, disease analysis, clinical research and medical device development.

Our integrated business intelligence solutions include a range of interactive online databases, analytical tools, reports and forecasts. Our analysis is supported by a 24/7 client support and analyst team. GlobalData has offices in New York, Boston, London, India and Singapore.

© GlobalData 2018. This product is licensed and is not to be photocopied.

Contact Us

If you have any queries about this report or would like further information, please contact us at the below telephone numbers or email address.

Phone: +44 (0) 161 359 5813

Email: reportstore@globaldata.com

Disclaimer. All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData. The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions and recommendations that GlobalData delivers will be based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such GlobalData can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect.